AbCellera Biologics Inc

	Invalid date	Dec-18	Dec-19	Dec-20	Dec-21
Total revenues	9 M	12 M	233 M	375 M	485 M
Cost of sales	-918000	-2 M	21 M	25 M	28 M
Gross operating profit	9 M	12 M	206 M	332 M	424 M

Selling Gen & administrative expense	1 M	2 M	7 M	31 M	56 M
Research & development expense	6 M	10 M	29 M	62 M	108 M
Operating income	841000	-2 M	164 M	222 M	227 M

floaterest income	0	0	0	0	0
floaterest expense	0	0	0	0	0
Other income net	-362000	186000	-300000	-855000	7 M
Pre-tax Income (EBT)	309000	-2 M	158 M	219 M	239 M

Income taxes	0	0	39 M	66 M	81 M
Net income from total operations	309000	-2 M	119 M	153 M	159 M
Minority floaterest	0	0	0	0	0
Total net income	309000	-2 M	119 M	153 M	159 M

Preferred dividends	16947	N/A	34 M	N/A	N/A
Net income available for common	292053	-2 M	85 M	153 M	159 M
Depreciation	918000	2 M	5 M	17 M	33 M
Amortization	0	0	0	0	0
Operating income before depreciation (EBITDA)	1 M	-155000	170 M	242 M	276 M
Total Income available for floaterest expense (EBIT)	0	0	0	0	0
Basic EPS total	0	-0.01	0.53	0.56	0.56
Diluted EPS total	0	-0.01	0.45	0.48	0.5

<< PREVIOUS STOCK

NEXT STOCK>>

Call: 1-877-778-8358

I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today